{"id":"https://openalex.org/W2885424851","doi":"https://doi.org/10.1158/1557-3125.advbc17-b34","title":"Abstract B34: Novel synergistic combination therapies with BET bromodomain inhibitors in triple-negative breast cancer","display_name":"Abstract B34: Novel synergistic combination therapies with BET bromodomain inhibitors in triple-negative breast cancer","publication_year":2018,"publication_date":"2018-08-01","ids":{"openalex":"https://openalex.org/W2885424851","doi":"https://doi.org/10.1158/1557-3125.advbc17-b34","mag":"2885424851"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.advbc17-b34","doi":"https://doi.org/10.1158/1557-3125.advbc17-b34","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.advbc17-b34","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002698554","display_name":"Samantha M. Bevill","orcid":"https://orcid.org/0000-0003-2264-9284","observed_orcids":["https://orcid.org/0000-0003-2264-9284"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha M. Bevill","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014356370","display_name":"Noah Sciaky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah Sciaky","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045554156","display_name":"Brian T. Golitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian T. Golitz","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065665275","display_name":"Naim U. Rashid","orcid":"https://orcid.org/0000-0002-7274-8259","observed_orcids":["https://orcid.org/0000-0002-7274-8259"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naim U. Rashid","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083411117","display_name":"Jon S. Zawistowski","orcid":"https://orcid.org/0000-0001-8493-9813","observed_orcids":["https://orcid.org/0000-0001-8493-9813"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon S. Zawistowski","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047612906","display_name":"Gary L. Johnson","orcid":"https://orcid.org/0000-0003-2867-0551","observed_orcids":["https://orcid.org/0000-0003-2867-0551"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary L. Johnson","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"8_Supplement","first_page":"B34","last_page":"B34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/adaptive-resistance","display_name":"adaptive resistance","score":0.8960000276565552},{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cdk9","display_name":"CDK9","score":0.7599999904632568},{"id":"https://openalex.org/keywords/p-tefb","display_name":"P-TEFb","score":0.824999988079071},{"id":"https://openalex.org/keywords/transcription-elongation","display_name":"transcription elongation","score":0.875},{"id":"https://openalex.org/keywords/enhancer-remodeling","display_name":"enhancer remodeling","score":0.9039999842643738},{"id":"https://openalex.org/keywords/aurora-kinases","display_name":"Aurora kinases","score":0.8050000071525574},{"id":"https://openalex.org/keywords/erk","display_name":"ERK","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.961209237575531},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.8524860143661499},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7990096807479858},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7114606499671936},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.6449967622756958},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5156518220901489},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.4973123371601105},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.44975537061691284},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4471837282180786},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.42854565382003784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4124966561794281},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37304994463920593},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.35201317071914673},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.15137049555778503},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09394887089729309},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07131600379943848}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.advbc17-b34","doi":"https://doi.org/10.1158/1557-3125.advbc17-b34","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.advbc17-b34","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6962621286","https://openalex.org/W2887046166","https://openalex.org/W2402088519","https://openalex.org/W2404594199","https://openalex.org/W2498818088","https://openalex.org/W2396125572","https://openalex.org/W3011851683","https://openalex.org/W6924966068","https://openalex.org/W2614698403","https://openalex.org/W2938383909"],"abstract_inverted_index":{"Abstract":[0],"Adaptive":[1,49],"resistance":[2],"to":[3,21,112,129,137,175,267,292,324],"targeted":[4,18,124],"cancer":[5,12,47,373],"therapies":[6,365],"is":[7,101],"a":[8,103,143,224],"universal":[9],"problem":[10],"in":[11,44,72,86,120,156,227,283,341,370,383],"treatment":[13],"where":[14],"tumor":[15,96,118,326],"cells":[16,119],"circumvent":[17],"pathway":[19],"inhibition":[20,36,181,245,307],"reactivate":[22],"growth":[23,71,139,328],"signaling.":[24],"In":[25],"our":[26],"previous":[27],"work,":[28],"we":[29,178,211,222],"observed":[30],"genome-wide":[31],"enhancer":[32],"remodeling":[33,275],"following":[34],"MEK":[35],"(MEKi)":[37],"capable":[38],"of":[39,106,117,140,164,182,204,255,273,285,296,301,333,377],"driving":[40],"adaptive":[41,115],"gene":[42],"transcription":[43],"triple-negative":[45,371],"breast":[46,372],"(TNBC).":[48],"enhancers":[50],"were":[51],"enriched":[52,146],"for":[53,131,147],"the":[54,114,171,198,205,217,231,247,253,294,299,378],"BET":[55,64,84,236,305,338,367],"bromodomain":[56,219,237,254,306,339,368],"protein":[57],"BRD4":[58],"and":[59,63,76,149,166,188,197,242,298,311,329],"cotreatment":[60],"with":[61,122,135,193,230,260,304,322,366],"MEKi":[62],"inhibitor":[65,220,249],"(JQ1)":[66],"could":[67],"durably":[68],"suppress":[69,138,325],"TNBC":[70,141,158],"multiple":[73,95,123],"cell":[74,159,264,327],"lines":[75,160,265],"preclinical":[77,107],"mouse":[78],"models.":[79],"There":[80,100],"are":[81,201,271],"currently":[82],"10":[83],"inhibitors":[85,111,132,369],"clinical":[87],"trials":[88],"being":[89],"tested":[90],"as":[91],"single":[92],"agents":[93],"across":[94,161,262],"types":[97],"including":[98,234],"TNBC.":[99,342],"also":[102],"growing":[104],"body":[105],"literature":[108],"using":[109,142,246,308],"epigenetic":[110,148],"block":[113],"ability":[116],"combination":[121,364],"therapies.":[125],"This":[126],"led":[127],"us":[128],"screen":[130,233],"that":[133,180,277,320],"synergize":[134,321],"JQ1":[136,165,232,261,323],"176-compound":[144],"library":[145,168],"kinase":[150],"inhibitors.":[151],"We":[152],"performed":[153,212],"synergy":[154,214,303],"screens":[155,215],"6":[157,162],"doses":[163],"each":[167],"compound.":[169],"Using":[170],"Bliss":[172],"Independence":[173],"model":[174],"assess":[176],"synergy,":[177],"found":[179,223],"MEK,":[183,235],"CDK9,":[184,196],"Aurora":[185,240],"Kinase,":[186,241],"CREBBP/P300,":[187],"BAZ2A/B":[189,244,269,297],"was":[190],"strongly":[191],"synergistic":[192,228,363],"JQ1.":[194],"BRD4,":[195],"acetyltransferase":[199],"CREBBP/P300":[200],"all":[202,263],"members":[203,272],"P-TEFb":[206],"transcriptional":[207,334],"elongation":[208],"complex.":[209],"When":[210],"additional":[213,331],"against":[216],"P300":[218],"CPI-637,":[221],"significant":[225],"overlap":[226],"targets":[229,252,319],"proteins,":[238],"ERK,":[239],"CDK9.":[243],"small-molecule":[248],"GSK2801,":[250],"which":[251],"BAZ2A/B,":[256],"synergized":[257],"significantly":[258],"stronger":[259],"compared":[266],"CPI637.":[268],"proteins":[270,340],"nucleosome":[274],"complexes":[276],"mediate":[278],"DNA":[279],"silencing":[280],"by":[281,337],"aiding":[282],"recruitment":[284],"histone":[286],"modifying":[287],"enzymes.":[288],"Ongoing":[289],"studies":[290],"seek":[291],"understand":[293],"role":[295],"mechanism":[300],"GSK2801":[302],"RNA":[309],"sequencing":[310,313],"ChIP":[312],"experiments.":[314],"These":[315],"results":[316],"define":[317],"novel":[318],"illuminate":[330],"mechanisms":[332],"regulation":[335],"driven":[336],"Citation":[343],"Format:":[344],"Samantha":[345],"M.":[346],"Bevill,":[347],"Noah":[348],"Sciaky,":[349],"Brian":[350],"T.":[351],"Golitz,":[352],"Naim":[353],"U.":[354],"Rashid,":[355],"Jon":[356],"S.":[357],"Zawistowski,":[358],"Gary":[359],"L.":[360],"Johnson.":[361],"Novel":[362],"[abstract].":[374],"In:":[375],"Proceedings":[376],"AACR":[379],"Special":[380],"Conference:":[381],"Advances":[382],"Breast":[384],"Cancer":[385,396],"Research;":[386],"2017":[387],"Oct":[388],"7-10;":[389],"Hollywood,":[390],"CA.":[391],"Philadelphia":[392],"(PA):":[393],"AACR;":[394],"Mol":[395],"Res":[397],"2018;16(8_Suppl):Abstract":[398],"nr":[399],"B34.":[400]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2018-08-22T00:00:00"}